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Conclusion: The reconstructed seed positions measured by 
the BV probe demonstrate excellent agreement with seed 
positions calculated using CT data with a maximum 
discrepancy of 1.78 mm. It was observed that 75% of seed 
positions were reconstructed within 1 mm of their nominal 
location. The DVH study was performed to evaluate the 
effect of reconstructed seed locations on estimated dose 
delivered. V100 showed a discrepancy of 0.604 cm3 between 
CT and BV-derived 3D seed distribution. The BV technique 
has proven to be an effective tool for quality assurance 
during LDR brachytherapy, providing anatomical and seed 
positioning information without need for external irradiation 
for imaging. 
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Purpose or Objective: There are multiple challenges behind 
developing an in vivo dosimeter for LDR brachytherapy. The 
dose rates are orders of magnitudes lower than in other 
therapy modalities, the detectors are known to be energy-
dependent, and introducing materials that are not tissue-
equivalent may perturb the dose deposition. The goal of this 
work is to develop a high sensitivity dosimeter based on 
plastic scintillation detectors (PSDs) that overcomes those 
challenges and to validate its performance for in vivo 
dosimetry. 
 
Material and Methods: The effect of the energy dependence 
of PSDs on dosimetry accuracy was studied using GEANT4 
Monte Carlo (MC) simulations adapted from the ALGEBRA 
source code developed for brachytherapy. The photon energy 
distribution at different positions around a modeled I-125 
source was obtained and convoluted to a typical PSD 
response. The effect of the different materials composing the 
PSD was also investigated.  
To measure dose rates as low as 10 nGy/s, the selection of 
each single element composing a typical PSD dosimetry 
system was revisited. A photon-counting photomultiplier tube 
(PMT) was used in combination with an optical fiber designed 
to collect more light from the scintillator. A spectral study 
was performed to determine the best combination of 
scintillator and optical fiber to use.  
Finally, doses up to a distance of 6.5 cm from a single I-125 
source of 0.76U (0.6 mCi) held at the center of a water 
phantom were measured. The PSD was moved at different 
radial and longitudinal positions from the source using an in-
house computer-controlled device developed for this study 
and allowing for sub-mm positioning accuracy. The 
measurements were compared to the expected values from 
the updated Task-Group 43 formalism. 
 
Results: The change in the energy distribution with position 
around the I-125 source was shown from MC simulations to 
have a limited impact on the PSD’s accuracy over the 
clinically relevant range (<1.2%). Therefore, the energy-
dependence can be neglected, as long as the PSD is 
calibrated using the same isotope. The effect of the different 
materials on the photon energy distribution was also shown 
to be limited (<0.1%). The different improvements made to 
the PSD dosimetry system are presented in Table 1. Those led 
to a 44 times better signal-to-noise ratio than for a typical 
PSD. Measurements with the PSD around a single I-125 source 
were shown to be in good agreement with the expected 
values (see Fig.1). The uncertainty was shown to be a 
balance between positioning uncertainty near the source and 
measurement uncertainty as the detector moves farther 
away from the source. 
 
 
 
 
Conclusion: This optimized PSD system was shown to be 
capable of accurate in-phantom dosimetry around a single 
LDR brachytherapy seed, which confirms the high sensitivity 
of the detector as a potential in vivo dosimeter for LDR 
brachytherapy applications. 
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Purpose or Objective: The development of MR-guided HDR 
brachytherapy has gained an increasing interest for delivering 
a high tumor dose safely. However, the update rate of MR-
based needle localization is inherently low and the required 
image interpretation is hampered by signal voids arising from 
blood vessels or calcifications, which limits the precision of 
the needle steering.  
This study aims to assess the potential of fiber optic sensing 
for real-time needle tracking during MR-guided intervention. 
For this, the MR compatibility of a fiber optic tracking system 
and its accuracy are evaluated. 
 
Material and Methods: Fiber optic tracking device: The 
device consists of a flexible stylet with three optic fibers 
embedded along its length, a broadband light source, a 
spectrum analyzer and a PC with Labview application. Along 
each fiber, Bragg gratings are evenly spaced at 20 mm 
intervals. To reconstruct the shape of a needle, the stylet is 
inserted inside the lumen of the needle. This set-up placed in 
the 1.5T MR-scanner provides real-time measurement of the 
needle profile, without adverse imaging artefacts since no 
ferromagnetic material is involved. 
MRI-acquisition protocol: 3D MR-images were acquired with a 
1.5T MR-scanner, using a 3D Spectral Presaturation with 
Inversion Recovery (SPIR) sequence (TR=2.9ms, TE=1.44ms, 
voxel size= 1.2×1.45×1mm^3, FOV=60×250×250mm^3). 
Experimental evaluation: The two following experiments 
were conducted: 
1. A needle was placed inside the MR-bore and its 
shape was imposed by a specially designed plastic 
mold with different known paths (see Fig. 1a). For 
path 1, 2 and 3, the shape of the needle was 
measured by fiber optic tracking during MR-imaging 
along 4 orientations (i.e 0°, 90°, 180°, 270°), by 
rotating the needle along its longitudinal axis. 
2. Four plastic catheters were introduced in an agar 
phantom. The corresponding catheter shapes were 
measured with fiber optic sensing during 
simultaneous MR imaging (see Fig. 1d, phantom 
shifted out of scanner for photograph). The MR-
based needle shape stemmed from a segmentation 
step followed by a polynomial fitting (order 5). A 
rigid registration of the obtained MR-based needle 
model and the fiber optic tracking was then 
performed. 
Assessment of the fiber optic tracking: The fiber optic 
needle tracking accuracy was quantified by calculating the 
Euclidian distances between: the gold-standard shapes and 
fiber optic based measurements (Experiment #1); MR- and 
fiber optic based measurements (Experiment #2). 
 
Results: For all tested needle shapes, the maximum absolute 
difference between the fiber optic based and the gold-
standard values was lower than 0.9mm (Experiment #1, Fig. 
1b and 1c). Over the 4 tested catheters, the maximal 
absolute difference between MR- and fiber optic based 
measurements was lower than 0.9mm (Experiment #2, Fig. 
1e, 1f and 1g). 
 
Conclusion: This study demonstrates that the employed fiber 
optic tracking device is able to monitor the needle bending 
during MR-imaging with an accuracy and update rate eligible 
for MR-guided intervention. 
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Purpose or Objective: MOSkin detectors coupled to a trans-
rectal ultrasound (TRUS) probe were used to perform in vivo 
dosimetry (IVD) on the rectal wall surface during US-based 
HDR prostate brachytherapy (BT). The system, called dual 
purpose probe (DPP), has proven to be an accurate tool to 
measure in vivo the integral dose, however discrepancies 
between planned and measured doses from each single 
catheter can be much higher than the overall discrepancies. 
In this work, three HDR prostate BT sessions were studied to 
find a possible distance and angle dependence correction 
function (CF) to be applied in real time to each single 
catheter, and data with and without the application of the 
obtained CF were compared. 
 
Material and Methods: The DPP can be sketched as follows: 
four MOSkin dosimeters are firmly attached to TRUS rectal 
probe and are connected to a multichannel reader which 
provides measurements of the voltage shifts (proportional to 
the dose) in the MOSkin sensitive layer caused by radiation 
exposure. A dedicated software plots and records the 
measured dose with each MOSkin as a function of time, 
allowing the identification of the dose contribution of each 
single catheter in real time. Based on the treatment plan 
data (i.e. planned source strength, dwell times and positions) 
a software was implemented in the Matlab environment to 
compute the dose contribution to the MOSkin from each 
catheter based on TG-43 algorithm. The software reports also 
the weighted average distance of source to MOSkin for each 
catheter and the resulting weighted polar angles. IVD data 
were acquired on three patients treated between June and 
